Summary
The fidelity of the protein production process is monitored by quality control machinery, which ensures that aberrant proteins are not deployed throughout the cell. A significant fraction (upwards of 30%) of proteins are degraded by proteasomes shortly after their synthesis, and we have termed such proteins defective ribosomal proteins (DRiPs). It is of interest and importance to characterize qualitatively and quantitatively this cohort of rapidly degraded nascent proteins. Quantitating DRiPs entails employing a standard pulse-chase protocol using radiolabeled amino acids. Protein degradation kinetics can be determined by either acid precipitation or SDS-PAGE. The introduction of proteasome inhibitors enables quantitation of proteasome-mediated protein degradation in vivo.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wickner, S., Maurizi, M. R., and Gottesman, S. (1999) Posttranslational quality control: folding, refolding, and degrading proteins. Science 286, 1888–1893.
Hartl, F. U. and Hayer-Hartl, M. (2002) Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295, 1852–1858.
Frydman, J. (2001) Folding of newly translated proteins in vivo: the role of molecular chaperones. Annu. Rev. Biochem. 70, 603–647.
Coux, O., Tanaka, K., and Goldberg, A. L. (1996) Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65, 801–847.
Voges, D., Zwickl, P., and Baumeister, W. (1999) The 26S proteasome: a molecular machine designed for controlled proteolysis. Annu. Rev. Biochem. 68, 1015–1068.
DeMartino, G. N. and Slaughter, C. A. (1999) The proteasome, a novel protease regulated by multiple mechanisms. J. Biol. Chem. 274, 22123–22126.
Rock, K. L. and Goldberg, A. L. (1999) Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17, 739–779.
Yewdell, J. W. and Bennink, J. R. (2001) Cut and trim: generating MHC class I peptide ligands. Curr. Opin. Immunol. 13, 13–18.
Goldberg, A. L., Cascio, P., Saric, T., and Rock, K. L. (2002) The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides. Mol. Immunol. 39, 147–164.
Wheatley, D. N., Giddings, M. R., and Inglis, M. S. (1980) Kinetics of degradation of “short-” and “long-lived” proteins in cultured mammalian cells. Cell Biol. Int. Rep. 4, 1081–1090.
Schubert, U., Anton, L. C., Gibbs, J., Norbury, C. C., Yewdell, J. W., and Bennink, J. R. (2000) Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404, 770–774.
Princiotta, M. F., Finzi, D., Qian, S. B., et al. (2003) Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18, 343–354.
Yewdell, J. W., Anton, L. C., and Bennink, J. R. (1996) Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? J. Immunol. 157, 1823–1826.
Yewdell, J. W. (2001) Not such a dismal science: the economics of protein synthesis, folding, degradation and antigen processing. Trends Cell Biol. 11, 294–297.
Kisselev, A. F. and Goldberg, A. L. (2001) Proteasome inhibitors: from research tools to drug candidates. Chem. Biol. 8, 739–758.
Rock, K. L., Gramm, C., Rothstein, L., et al. (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78, 761–771.
Craiu, A., Gaczynska, M., Akopian, T., et al. (1997) Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J. Biol. Chem. 272, 13437–13445.
Meng, L., Mohan, R., Kwok, B. H., Elofsson, M., Sin, N., and Crews, C. M. (1999) Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc. Natl. Acad. Sci. USA 96, 10403–10408.
Qian, S. B., Ott, D. E., Schubert, U., Bennink, J. R., and Yewdell, J. W. (2002) Fusion proteins with COOH-terminal ubiquitin are stable and maintain dual functionality in vivo. J. Biol. Chem. 277, 38818–38826.
Wheatley, D. N. and Inglis, M. S. (1985) Turnover of nascent proteins in HeLa-S3 cells and the quasi-linear incorporation kinetics of amino acids. Cell Biol. Int. Rep. 9, 463–470.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Qian, SB., Bennink, J.R., Yewdell, J.W. (2005). Quantitating Defective Ribosome Products. In: Patterson, C., Cyr, D.M. (eds) Ubiquitin-Proteasome Protocols. Methods in Molecular Biology™, vol 301. Humana Press. https://doi.org/10.1385/1-59259-895-1:271
Download citation
DOI: https://doi.org/10.1385/1-59259-895-1:271
Publisher Name: Humana Press
Print ISBN: 978-1-58829-252-0
Online ISBN: 978-1-59259-895-3
eBook Packages: Springer Protocols